HIV-1 GP41 neutralizing antibodies and uses thereof

The present invention discloses neutralizing antibodies and antigen binding fragments of these antibodies that specifically bind to HIV-1Env. Nucleic acids, vectors and host cells encoding these antibodies are also provided. Methods of detecting HIV-1 using these antibodies are disclosed. In additio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHUANG GWO-YU, SHAPIRO LAWRENCE, KWONG PETER, BENDER MICHAEL, MAKSOU LU, JOUNI, BAILER ROBERT, CARLTON, KENNETH, GEORGIEV IVELIN, O'DELL SIDNEY, LAOUT MOHAMED, PEGU AMARENDRA, COOPER JEREMY, ASOKAN MANIKANDAN, CONNORS MARK, KUELTZO LISA, ZHANG BAOSHAN, MCKEE KRISTINA, SCHWARTZ RICHARD, GINDIN TAMIR, KWON YOUNG DO, OFEK GILAD
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention discloses neutralizing antibodies and antigen binding fragments of these antibodies that specifically bind to HIV-1Env. Nucleic acids, vectors and host cells encoding these antibodies are also provided. Methods of detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragments, nucleic acids and vectors to prevent and/or treat HIV-1 infection is disclosed. 本发明公开了特异结合HIV-1Env的中和抗体和这些抗体的抗原结合片段。还提供了编码这些抗体的核酸、载体和宿主细胞。公开了采用这些抗体检测HIV-1的方法。另外，公开了这些抗体、抗原结合片段、核酸和载体防止和/或治疗HIV-1感染的用途。